On ECHEMI
Home > Drugs > Hefei Shuboshi Pharmaceutical Co., Ltd.
Hefei Shuboshi Pharmaceutical Co., Ltd.
  • Founded in:

    2003-07-08
  • Country:

    China China
  • Address:

    No. 35, Tianzhi Road, High-tech Zone, Hefei City, Anhui Province
  • Tax NO.:

    9134010075099629XX
  • Registered Funds:

    18.2 million yuan
  • Email:

Related Drugs
Vitamin D2 Calcium Phosphate Tablets
This product is a compound preparation. Each tablet contains 2500 units of vitamin D and 150 mg of calcium hydrogen phosphate (equivalent to 36 mg of calcium).
Name Description Content CAS NO. Registered Holders
Vitamin D2

It is an essential substance for human growth and development, especially for fetuses and infants. It participates in calcium and phosphorus metabolism, promotes their absorption, and plays an important role in bone formation.

More

It is an essential substance for human growth and development, especially for fetuses and infants. It participates in calcium and phosphorus metabolism, promotes their absorption, and plays an important role in bone formation.

500unit 50-14-6 13
Calcium

It plays an important role in the formation of human bones, reconstruction of bone tissue, muscle contraction, nerve transmission, coagulation mechanism and maintaining capillary permeability.

More

It plays an important role in the formation of human bones, reconstruction of bone tissue, muscle contraction, nerve transmission, coagulation mechanism and maintaining capillary permeability.

36mg 7440-70-2 0
Dry yeast flakes
Each tablet of this product contains 0.3 grams of dry yeast as the main ingredient.
Name Description Content CAS NO. Registered Holders
Yeast extract

This product is the dried bacteria of brewer's yeast, which is rich in B vitamins and has an auxiliary therapeutic effect on indigestion.

More

This product is the dried bacteria of brewer's yeast, which is rich in B vitamins and has an auxiliary therapeutic effect on indigestion.

0.3g 8013-01-2 4
Metoprolol tartrate sustained-release tablets
The main ingredients and chemical names of this product are: 1-isopropylamino-3-[p-(2-methoxyethyl)phenoxy]-2-propanol L()-tartrate
Name Description Content CAS NO. Registered Holders
Metoprolol tartrate

This drug belongs to Class 2A, i.e., a β1-receptor blocker without partial agonist activity (cardioselective β-receptor blocker). It has a selective blocking effect on β1-receptors, no PAA (partial agonist activity), and no membrane stabilizing effect. Its effect on blocking β-receptors is approximately equal to that of propranolol (PP), and its selectivity for β1-receptors is slightly inferior to that of atenolol. Metoprolol's effects on the heart, such as slowing heart rate, inhibiting cardiac contractility, reducing automaticity, and delaying atrioventricular conduction time, are similar to those of propranolol and atenolol (AT). Its effect on reducing elevated blood pressure and heart rate during exercise testing is also similar to that of PP and AT. Its contraction effect on vascular and bronchial smooth muscle is weaker than that of PP, so its effect on the respiratory tract is also smaller, but still stronger than that of AT. Metoprolol can also reduce plasma renin activity.

More

This drug belongs to Class 2A, i.e., a β1-receptor blocker without partial agonist activity (cardioselective β-receptor blocker). It has a selective blocking effect on β1-receptors, no PAA (partial agonist activity), and no membrane stabilizing effect. Its effect on blocking β-receptors is approximately equal to that of propranolol (PP), and its selectivity for β1-receptors is slightly inferior to that of atenolol. Metoprolol's effects on the heart, such as slowing heart rate, inhibiting cardiac contractility, reducing automaticity, and delaying atrioventricular conduction time, are similar to those of propranolol and atenolol (AT). Its effect on reducing elevated blood pressure and heart rate during exercise testing is also similar to that of PP and AT. Its contraction effect on vascular and bronchial smooth muscle is weaker than that of PP, so its effect on the respiratory tract is also smaller, but still stronger than that of AT. Metoprolol can also reduce plasma renin activity.

56392-17-7 49
Norfloxacin Capsules
Norfloxacin
Name Description Content CAS NO. Registered Holders
Norfloxacin

This product is a fluoroquinolone antibacterial drug with a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria. It has good antibacterial activity against the following bacteria in vitro: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacter species, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. Norfloxacin also has antibacterial activity against multi-drug resistant bacteria in vitro. It also has good antibacterial effects on penicillin-resistant Neisseria gonorrhoeae, Haemophilus influenzae and Moraxella catarrhalis. Norfloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

This product is a fluoroquinolone antibacterial drug with a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria. It has good antibacterial activity against the following bacteria in vitro: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacter species, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. Norfloxacin also has antibacterial activity against multi-drug resistant bacteria in vitro. It also has good antibacterial effects on penicillin-resistant Neisseria gonorrhoeae, Haemophilus influenzae and Moraxella catarrhalis. Norfloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

70458-96-7 35
Levofloxacin Hydrochloride Capsules
The main ingredient of this product is levofloxacin hydrochloride. Chemical name: (S)-(-)-9-fluoro-2.3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-fluoro-7H pyridine benzene Molecular weight: C18H20FN3O4
Name Description Content CAS NO. Registered Holders
Levofloxacin hydrochloride

This product has a broad-spectrum antibacterial effect and has antibacterial activity against most Enterobacteriaceae, Gram-positive bacteria, Mycoplasma pneumoniae, Chlamydia pneumoniae, etc., but has poor effects on anaerobic bacteria and enterococci. Its mechanism of action is to inhibit the activity of bacterial DNA gyrase, prevent the synthesis and replication of bacterial DNA, and cause bacterial death.

More

This product has a broad-spectrum antibacterial effect and has antibacterial activity against most Enterobacteriaceae, Gram-positive bacteria, Mycoplasma pneumoniae, Chlamydia pneumoniae, etc., but has poor effects on anaerobic bacteria and enterococci. Its mechanism of action is to inhibit the activity of bacterial DNA gyrase, prevent the synthesis and replication of bacterial DNA, and cause bacterial death.

177325-13-2 18
  • 1
  • 2
  • Go to Page Go
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.